Microalgae Global Market Expected to Exceed $2 Billion by 2029

The global microalgae market is projected to surpass $2 billion by 2029, growing at a 7% CAGR. North America, led by the USA, will be the largest region, driven by demand for dietary supplements and expanding cosmetic and aquaculture industries. Spirulina will be the largest product type, with food and beverage dominating applications. Significant growth opportunities exist in spirulina, commercialization, and infused food and beverage products, reflecting a shift towards sustainable bioeconomy models.

The global microalgae market is poised for significant growth, with a projection to exceed $2 billion by 2029, achieving a robust 7% compound annual growth rate (CAGR). According to The Business Research Company's report, North America will lead this expansion, valued at $524 million in 2029, with the USA being the largest country at $444 million. This regional dominance is attributed to increasing demand for dietary supplements and the burgeoning cosmetic and personal care industry.Key market segments reveal that Spirulina will be the largest by type, accounting for 36% or $721 million, driven by its high protein and antioxidant content. The business channel will dominate distribution, representing 50% or $1008 million, fueled by bulk demand from various industries. In terms of application, the food and beverage sector is expected to be the largest, capturing 20% or $404 million, spurred by the rising preference for natural colorants and plant-based proteins.Growth factors include surging demand for dietary supplements, expanded use in aquaculture and animal feed, the growing cosmetic and personal care industry, and advancements in the pharmaceutical sector. These drivers contribute varying annual growth percentages, collectively reshaping supply chains. Major growth opportunities are identified in the spirulina market, microalgae commercialization and distribution, and microalgae-infused food and beverage market, which together are projected to contribute over $2 billion, emphasizing a global shift towards sustainable biotechnological transformation.